HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DLMM as a lossless one-shot algorithm for collaborative multi-site distributed linear mixed models.

Abstract
Linear mixed models are commonly used in healthcare-based association analyses for analyzing multi-site data with heterogeneous site-specific random effects. Due to regulations for protecting patients' privacy, sensitive individual patient data (IPD) typically cannot be shared across sites. We propose an algorithm for fitting distributed linear mixed models (DLMMs) without sharing IPD across sites. This algorithm achieves results identical to those achieved using pooled IPD from multiple sites (i.e., the same effect size and standard error estimates), hence demonstrating the lossless property. The algorithm requires each site to contribute minimal aggregated data in only one round of communication. We demonstrate the lossless property of the proposed DLMM algorithm by investigating the associations between demographic and clinical characteristics and length of hospital stay in COVID-19 patients using administrative claims from the UnitedHealth Group Clinical Discovery Database. We extend this association study by incorporating 120,609 COVID-19 patients from 11 collaborative data sources worldwide.
AuthorsChongliang Luo, Md Nazmul Islam, Natalie E Sheils, John Buresh, Jenna Reps, Martijn J Schuemie, Patrick B Ryan, Mackenzie Edmondson, Rui Duan, Jiayi Tong, Arielle Marks-Anglin, Jiang Bian, Zhaoyi Chen, Talita Duarte-Salles, Sergio Fernández-Bertolín, Thomas Falconer, Chungsoo Kim, Rae Woong Park, Stephen R Pfohl, Nigam H Shah, Andrew E Williams, Hua Xu, Yujia Zhou, Ebbing Lautenbach, Jalpa A Doshi, Rachel M Werner, David A Asch, Yong Chen
JournalNature communications (Nat Commun) Vol. 13 Issue 1 Pg. 1678 (03 30 2022) ISSN: 2041-1723 [Electronic] England
PMID35354802 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2022. The Author(s).
Topics
  • Algorithms
  • COVID-19 (epidemiology)
  • Confidentiality
  • Databases, Factual
  • Humans
  • Linear Models

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: